On early September 2023, Eurovisco
held its annual consensus meeting gathering Europeans osteoarthritis experts
This year’s aim was to determine the imaging and clinical criteria that influence the success rate of treatment of knee osteoarthritis by injection of an HA-based viscosupplement.
Dr Thierry Conrozier masterfully chaired this meeting and Labrha
had the pleasure to sponsor this event again.
An article will soon be released gathering all the recommendations issued from this consensus meeting.
We will publish it on this page shortly.